Find More Contacts for Heptares Therapeutics
Protected Content
Director Management
1 email found
View contacts for Heptares Therapeutics to access new leads and connect with decision-makers.
View All Contacts
  • Company Type For Profit
  • Contact Email info@heptares.com
  • Phone Number +441707358628

Heptares Therapeutics is a drug discovery company focused on novel small-molecule drugs targeting G-protein-coupled receptors (GPCRs), the largest family of druggable targets.

The Company has developed a unique, transformational and proprietary technology for making purified, stabilised and functional GPCRs (known as StaRs, Stabilised

Receptors), overcoming a major limiting factor to the development of new drugs targeting this group.

Lists Featuring This Company

United Kingdom Companies With Fewer Than 50 Employees (Top 10K)
9,747 Number of Organizations â€¢ $69.5B Total Funding Amount â€¢ 26,468 Number of Investors
Europe, Middle East, and Africa (EMEA) Biotechnology Companies (Top 10K)
9,958 Number of Organizations â€¢ $141.4B Total Funding Amount â€¢ 14,601 Number of Investors
United Kingdom Companies With More Than 10 Employees (Top 10K)
10,000 Number of Organizations â€¢ $446.8B Total Funding Amount â€¢ 29,743 Number of Investors
United Kingdom Companies that Exited (Top 10K)
9,884 Number of Organizations â€¢ $235B Total Funding Amount â€¢ 7,795 Number of Investors
Heptares Therapeutics was acquired by Sosei Group for $400M on Feb 22, 2015.

Frequently Asked Questions

Where is Heptares Therapeutics's headquarters? Heptares Therapeutics is located in Welwyn Garden City, Hertford, United Kingdom.Who invested in Heptares Therapeutics? Heptares Therapeutics has 6 investors including Teva Pharmaceuticals and Takeda Ventures.How much funding has Heptares Therapeutics raised to date? Heptares Therapeutics has raised .When was the last funding round for Heptares Therapeutics? Heptares Therapeutics closed its last funding round on May 18, 2017 from a Venture - Series Unknown round.Who are Heptares Therapeutics's competitors? Alternatives and possible competitors to Heptares Therapeutics may include KSQ TherapeuticsAclaris Therapeutics, and Adamas Pharmaceuticals.